A high-throughput microfluidic microphysiological system (PREDICT-96) to recapitulate hepatocyte function in dynamic, re-circulating flow conditions.

Microphysiological systems (MPSs) are dynamic cell culture systems that provide micro-environmental and external cues to support physiologically relevant, organ-specific functions. Recent progresses in MPS fabrication technologies have enabled the development of advanced models to capture microenvironments with physiological relevance, while increasing throughput and reducing material-based artefacts. In addition to conventional cell culture systems, advanced MPSs are emerging as ideal contenders for disease modeling and incorporation into drug screening. Since liver is a central organ for drug metabolism, liver-on-chip models have been developed to recapitulate hepatic microenvironment with varying complexities, while allowing long-term culture. Recently, we have developed a novel thermoplastic, oxygen-permeable MPS for primary human hepatocyte (PHH) culture. Herein, we have adapted and extended the MPS to a) a 96 microfluidic array (PREDICT-96 array) and b) integrated a novel, ultra-low volume, re-circulating pumping system (PREDICT-96 pump) - collectively known as the PREDICT-96 platform. The PREDICT-96 platform conforms to the industrial standard 96-well footprint and enables media re-circulation. First, we demonstrate the introduction of PHHs into the PREDICT-96 array using standard handling procedures for multi-well plates and allow cells to stabilize in static conditions. Next, we introduce recirculating flow into the bottom channel (using PREDICT-96 pump) to mimic mass transport in vivo. Our results indicate an increase in metabolic and secretory functions of PHHs in the PREDICT-96 platform, and their maintenance over 10 days of flow. Furthermore, long-term culture with fluid flow allows for the periodic introduction of media components (e.g., fatty acids, cytokines) and capture cellular responses to chronic stimuli. The low-volume footprint of the pump and small media volume in the MPS allow for the interrogation of hepatic responses incorporating secretion feedback to a stimulus, which is essential for disease model development and drug interrogation. We envision future development of this liver model to incorporate key primary hepatic cells, multi-cellular co-cultures and adaptation, integration with high-throughput analytical tools.

[1]  Uwe Marx,et al.  Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery. , 2018, Annual review of pharmacology and toxicology.

[2]  S. Tay,et al.  Microfluidic cell culture. , 2014, Current opinion in biotechnology.

[3]  Luke P. Lee,et al.  Microfluidic environment for high density hepatocyte culture , 2008, Biomedical microdevices.

[4]  David J Hughes,et al.  Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease , 2017, World journal of gastroenterology.

[5]  Martin L. Yarmush,et al.  Isolation and co-culture of rat parenchymal and non-parenchymal liver cells to evaluate cellular interactions and response , 2016, Scientific Reports.

[6]  Ronan M. T. Fleming,et al.  Advantages and challenges of microfluidic cell culture in polydimethylsiloxane devices. , 2015, Biosensors & bioelectronics.

[7]  Luke P. Lee,et al.  An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture. , 2007, Biotechnology and bioengineering.

[8]  Uwe Marx,et al.  Chip-based liver equivalents for toxicity testing--organotypicalness versus cost-efficient high throughput. , 2013, Lab on a chip.

[9]  T B F Woodfield,et al.  A 96-well microplate bioreactor platform supporting individual dual perfusion and high-throughput assessment of simple or biofabricated 3D tissue models. , 2018, Lab on a chip.

[10]  M. Yarmush,et al.  Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions. , 2016, Tissue engineering. Part B, Reviews.

[11]  Ivan Rusyn,et al.  In vitro models for liver toxicity testing. , 2013, Toxicology research.

[12]  Thomas Hankemeier,et al.  Microfluidic titer plate for stratified 3D cell culture. , 2013, Lab on a chip.

[13]  Lucas H. Hofmeister,et al.  Scaling and systems biology for integrating multiple organs-on-a-chip. , 2013, Lab on a chip.

[14]  Volker M Lauschke,et al.  Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates. , 2016, Chemical research in toxicology.

[15]  José Vicente Castell,et al.  A human hepatocellular in vitro model to investigate steatosis. , 2007, Chemico-biological interactions.

[16]  P Smith,et al.  Concordance of the toxicity of pharmaceuticals in humans and in animals. , 2000, Regulatory toxicology and pharmacology : RTP.

[17]  Alberto Revelli,et al.  Cancer and fertility preservation: international recommendations from an expert meeting , 2016, BMC Medicine.

[18]  Michael L Shuler,et al.  Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow. , 2015, Lab on a chip.

[19]  Christopher Probst,et al.  High-throughput organ-on-a-chip systems: Current status and remaining challenges , 2018, Current Opinion in Biomedical Engineering.

[20]  Maarten Merkx,et al.  Colorful Protein-Based Fluorescent Probes for Collagen Imaging , 2014, PloS one.

[21]  Stephen A Hoang,et al.  Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis. , 2016, JCI insight.

[22]  Lucie A Low,et al.  Tissue chips to aid drug development and modeling for rare diseases , 2016, Expert opinion on orphan drugs.

[23]  M L Yarmush,et al.  Hepatocytes in collagen sandwich: evidence for transcriptional and translational regulation , 1992, The Journal of cell biology.

[24]  Francois Berthiaume,et al.  Automated image analysis method for detecting and quantifying macrovesicular steatosis in hematoxylin and eosin–stained histology images of human livers , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[25]  J. Perkins,et al.  Are we reporting the same thing? , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[26]  M. Toner,et al.  Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: hepatocytes cultured in a sandwich configuration , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  Manjunath Hegde,et al.  In vitro platforms for evaluating liver toxicity , 2014, Experimental biology and medicine.

[28]  S. Sugiura,et al.  A multi-throughput multi-organ-on-a-chip system on a plate formatted pneumatic pressure-driven medium circulation platform. , 2017, Lab on a chip.

[29]  David Ogilvie,et al.  Reliability and Validity of the Transport and Physical Activity Questionnaire (TPAQ) for Assessing Physical Activity Behaviour , 2014, PloS one.

[30]  Matteo Ricchi,et al.  Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes , 2009, Journal of gastroenterology and hepatology.

[31]  D. Tagle,et al.  Microphysiological Systems (“Organs‐on‐Chips”) for Drug Efficacy and Toxicity Testing , 2017, Clinical and translational science.

[32]  T. Pruett,et al.  Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro. , 2013, American journal of physiology. Cell physiology.

[33]  S. George,et al.  Design considerations to minimize the impact of drug absorption in polymer-based organ-on-a-chip platforms. , 2017, Lab on a chip.

[34]  D. Ingber,et al.  Microfluidic organs-on-chips , 2014, Nature Biotechnology.

[35]  Murat Cirit,et al.  Integrated gut/liver microphysiological systems elucidates inflammatory inter‐tissue crosstalk , 2017, Biotechnology and bioengineering.

[36]  Maarten Merkx,et al.  Fluorescently labeled collagen binding proteins allow specific visualization of collagen in tissues and live cell culture. , 2006, Analytical biochemistry.

[37]  A. Salter,et al.  Metabolic fate of oleic acid, palmitic acid and stearic acid in cultured hamster hepatocytes. , 1996, The Biochemical journal.

[38]  Adam S. Hayward,et al.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME , 2013, Archives of Toxicology.

[39]  Manjunath Hegde,et al.  Long-term maintenance of a microfluidic 3D human liver sinusoid. , 2016, Biotechnology and bioengineering.

[40]  Stephen L. Chen,et al.  Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells. , 2010, American journal of translational research.

[41]  M L Yarmush,et al.  Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies. , 2015, Technology.

[42]  Martin L Yarmush,et al.  Liver endothelial cells promote LDL‐R expression and the uptake of HCV‐like particles in primary rat and human hepatocytes , 2006, Hepatology.

[43]  Teun Bousema,et al.  Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data , 2016, BMC Medicine.

[44]  Jeffrey T. Borenstein,et al.  Microfluidic Cell Culture Platforms to Capture Hepatic Physiology and Complex Cellular Interactions , 2018, Drug Metabolism and Disposition.

[45]  Albert Gough,et al.  A human liver microphysiology platform for investigating physiology, drug safety, and disease models , 2016, Experimental biology and medicine.

[46]  O. B. Usta,et al.  Dynamic interplay of flow and collagen stabilizes primary hepatocytes culture in a microfluidic platform. , 2014, Lab on a chip.

[47]  Yu Du,et al.  Mimicking liver sinusoidal structures and functions using a 3D-configured microfluidic chip. , 2017, Lab on a chip.

[48]  Uwe Marx,et al.  The ascendance of microphysiological systems to solve the drug testing dilemma , 2017, Future science OA.

[49]  Brigitte Vollmar,et al.  Noninvasive in vivo analysis of the human hepatic microcirculation using orthogonal polorization spectral imaging , 2003, Transplantation.

[50]  S. Tseng,et al.  Types of Collagen Synthesized by Normal Rat Liver Hepatocytes in Primary Culture , 2007, Hepatology.